Serum PD-L1 levels increased over the course of treatment in 74% of patients, but this finding did not reach statistical significance ( P =0.16).
← all excerpts
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.
1
0.1600
0.1600